Kontakt 2005, 7(1-2):164-168 | DOI: 10.32725/kont.2005.033

Is it necessary to think about tetanus?Biomedicine

Oto Masár*, Katarína Galková, Ján Murgaš
Klinika anesteziológie a intenzívnej medicíny UKF a FN Nitra

The authors present a case of a young woman admitted for generalized cramps of unexplained origin. The condition was concluded as tetanus based on clinical symptoms and responses to the therapy. In the article, the tetanus pathological physiology and therapy is also analyzed.

Keywords: tetanus; cramps; antitetanic immunoglogulin

Published: June 29, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Masár O, Galková K, Murgaš J. Is it necessary to think about tetanus? Kontakt. 2005;7(1-2):164-168. doi: 10.32725/kont.2005.033.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abrutyn E, Berlin JA. 1991: Intrathecal therapy in tetanus, a meta-analysis. JAMA; 266: 2262-7. Go to original source... Go to PubMed...
    2. Agarwal M, Thomas K, Peter JV, Jeyaseelan L, Cherian AM. 1998: A randomised double-blind sham controlled study of intrathecal human anti-tetanus immunoglobulin in the management of tetanus. Natl Med J India;11: 209-12. Go to PubMed...
    3. Armitage P, Clifford R. 1978: Prognosis in tetanus: use of data from therapeutic trial. J Infect Dis;138: 1-8. Go to original source... Go to PubMed...
    4. Bakoš, E. 2004: Chirurgia pre FSVaZ UKF, Nitra
    5. Barone AA, Raineri HC, Ferreira JM. 1976: Tétano: aspectos epidemiológicos, clínicos e terapêuticos. Análise de 461 casos. Rev Hosp Clin Fac Med Sao Paulo;31: 215-25. Go to PubMed...
    6. Bleck TP 2000: Clostridium tetani (tetanus). In: Mandell GL, Bennett JE, Dolin R, eds. Man-dell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia: Churchill Livingstone: 2537-43.
    7. Ďurišová, A. 2002: Zásady farmakoterapie v detskom veku. In: Kriška, M. a kol: Memorix klinickej farmakológie. SAP, s. 145-154.
    8. Ďurišová, A. 2004a: Antimikrobiálna chemoterapia v neonatológii. Acta Chemother., 13, 2-3, s. 77 - 80.
    9. Ďurišová, A. 2004b: Zlyhanie farmakoterapie v detskom veku. Čes.-slov. Pediat., 59, 11, s. 589-594.
    10. Ďurišová, A., Kriška, M. 2001: Farmakokinetika liečiv u novorodencov a malých detí. Čs. pediat., 56, s. 137-142.
    11. Edmondson RS, Flowers MW. 1979: Intensive care in tetanus: management, complications and mortality in 100 cases. BMJ;1: 1401-4. Go to original source... Go to PubMed...
    12. Friedman LM, Furberg CD, Demets DL. 1996: Fundamentals of clinical trials, 3rd ed. St Louis, MI: Mosby.
    13. Gupta PS, Goyal S, Kapoor R, Batra VK, Jain BK. 1980: Intrathecal human tetanus immunoglobulin in early tetanus. Lancet;2: 439-40. Go to original source... Go to PubMed...
    14. Harding-Goldson HE, Hanna WJ. 1995: Tetanus: a recurring intensive care problem. J Trop Med Hyg;98: 179-84.
    15. Keswani NK, Singh AK, Upadhyana KD. 1980: Intrathecal tetanus anti-toxin in moderate and severe tetanus. J Indian Med Assoc;75: 67-9. Go to PubMed...
    16. List WF. 1981: The immediate treatment of tetanus with high doses of human tetanus antitoxin. Notfallmedizin;7: 731-3.
    17. Miranda Filho D, Ximenes R, Barone A, Vaz V, Vieira. 2003: Classificação clínica de pacientes com tétano para monitoramento da resposta a medidas terapêuticas. Braz J Infect Dis;7(suppl 1): S18.
    18. Miranda Filho DB, Ximenes RAA, Bernardino SN, Escarião AG. 1996: Caracterização epidemiológica do tétano no estado de Pernambuco no período de 1981 a 1995. Resumos do IX Congresso Brasileiro de Infectologia; Aug 25-9; Recife. Sociedade Brasileira de Infectologia.
    19. Miranda Filho DB, Ximenes RAA, Bernardino SN, Escarião AG. 2000: Identification of risk factors for death from tetanus in Pernambuco, Brazil. A case control study. Rev Inst Med Trop Sao Paulo;42: 333-9. Go to original source... Go to PubMed...
    20. Rossano C, Giugliano F. 1970: Prime esperienze e risultati terapeutici con immunoglobuline umane antitetaniche per via subaracnoidea. Minerva Anestesiol;36: 725-7. Go to PubMed...
    21. Sanders RKM, Martyn B, Joseph R, Peacock ML. 1977: Intrathecal antitetanus serum (horse) in the treatment of tetanus. Lancet;1: 974-7. Go to original source... Go to PubMed...
    22. Thomas PP, Crowell EB, Mathew M. 1982: Intrathecal anti-tetanus serum (ATS) and parenteral betamethasone in treatment of tetanus. Trans R Soc Trop Med Hyg;76: 620-3. Go to original source... Go to PubMed...
    23. Thwaites CL, Farrar JJ. 2003: Preventing and treating tetanus. The challenge continues in the face of neglect and lack of research. BMJ; 326: 117-8 Go to original source... Go to PubMed...
    24. Udwadia FE, Lall A, Udwadia ZF, Sekhar M, Vora A. 1987: Tetanus and its complications: intensive care and management experience in 150 Indian patients. Epidemiol Infect; 99: 675-84. Go to original source... Go to PubMed...
    25. Vakil BJ, Armitage P, Clifford RE, Laurence DR. 1979: Therapeutic trial of intracisternal human tetanus immunoglobulin in clinical tetanus. Trans R Soc Trop Med Hyg;73: 579-83. Go to original source... Go to PubMed...

    Return to the content